Table 2 Comparison of basic clinical data in the study and control group
Parameter | AMI group | Control group | p |
|---|---|---|---|
n | 71 | 20 | |
Age (years) | 60.2 ± 11.9 59.5 (35.0-84.0) | 60.1 ± 7.9 60.5 (49.0-76.0) | ns |
Men n (%) | 53 (75%) | 17 (85%) | ns |
Women n (%) | 18 (25%) | 3 (15%) | ns |
EF (%) | 49.9 ± 11.6 51.1 (19–72) | 45.9 ± 17.2 55 (14–69) | ns |
SV (ml) | 78.1 ± 21.7 75.6 (39.9-151.0) | 92.4 ± 23.0 92 (38–128) | ns |
Infarct location: | |||
LAD | 23 (32%) | 10 (50%) | ns |
RCA | 41 (58%) | 6 (30%) | |
LCX | 7 (10%) | 4 (20%) | |
TIMI pre PCI: | |||
TIMI - 0 | 53 (75%) | 13 (65%) | ns |
TIMI - 1 | 8 (11%) | 3 (15%) | |
TIMI - 2 | 7 (10%) | 3 (15%) | |
TIMI - 3 | 3 (4%) | 1 (5%) | |
TIMI post PCI | |||
TIMI - 0 | 1 (1%) | 0 (0%) | ns |
TIMI - 1 | 2 (3%) | 1 (5%) | |
TIMI - 2 | 16 (22%) | 3 (15%) | |
TIMI - 3 | 52 (74%) | 16 (80%) | |
PCI - CMR time (days) | 2.5 ± 1.5 2 (1–7) | 293 ± 42 298 (235–354) | <0.001 |
Time to pPCI (hours) | 5.1 ± 3.7 5 (1–12) | 4.8 ± 4.1 5 (2–12) | ns |
Value: mean ± SD median (min-max); n (%) | |||